Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

W001 - Hands-on: Practical Anatomy for Dermal Fillers

Monday, March 4; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify structural and functional facial anatomy relevant to filler injections.
  • Utilize proper techniques for soft tissue augmentation pan-facially.
  • Implement peri-procedural assessment and strategies for avoidance and management of complications.

Description

This hands-on training session for dermal fillers will begin with a video review of anatomy presented by Dr. Braz. Participants will then break into groups of beginner/intermediate or intermediate/advanced injectors. Faculty will circulate through each of stations focused on a specific anatomical region of the face. Each demonstration table will be equipped with high fidelity cutaneous surgical training models for practice injections using both needles and cannulas. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.

Disclosures

  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Braz, Andre, MD: Allergan, Inc – A(H), SP(H); Merz Pharmaceuticals, LLC – SP(Fees);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candela Corporation – A(H); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – A(NC); Valeant Pharmaceuticals North America LLC – C(H);
  • Glaser, Dee Anna, MD: Allergan, Inc. – I(Grants/Research Funding), O(H); American Society of Dermatologic Surgery – B(NC); Atacama Therapeutics – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Dermira – A(H), I(Grants/Research Funding), Speaker/Faculty Education(H); Galderma Laboratories, L.P. – A(H); Galderma Research & Development, LLC – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(H);
  • Green, Jeremy, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc – A(H), I(Grants/Research Funding), SP(H); Bonti – A(H); Brickell Biotech, Inc. – I(Grants/Research Funding); Candesant Biomedical, Inc. – I(Grants/Research Funding), SH(ST); Clarisonic – A(H); Cutera, Inc. – SP(H); Cynosure, Inc. – SP(EQ); Endo International plc – A(H); Evolus, Inc. – A(H); Galderma Laboratories, L.P. – I(Grants/Research Funding), SP(H); Galderma USA – A(H); Lutronic – I(Grants/Research Funding); Merz Aesthetics – A(H), I(Grants/Research Funding), SP(H); Pulse Biosciences – I(Grants/Research Funding); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding); Sienna Labs, Inc. – A(H), I(Grants/Research Funding);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Rossi, Anthony, MD: A. Ford Memorial Research Grant – I(Grants/Research Funding); Allergan, Inc – A(H); ASDS – I(Grants/Research Funding); Biofrontera AG – A(H); Cutera, Inc. – Speaker/Faculty Education(H); EBSCO Industries, Inc. – C(Fees); Evolus, Inc. – A(H); Guthy-Renker – C(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(H); LAM Therapeutics – I(H); Regeneron – A(H); Skin Cancer Foundation – O(Grants/Research Funding); Skinfix, Inc. – A(H);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
  • Welsh, Kathleen M., MD: Allergan, Inc – A(H), SH(NC); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – SH(NC);
  • Woodward, Julie, MD: Allergan, Inc – C(H); Galderma USA – Speaker/Faculty Education(H); Merz Aesthetics – A(H); Prollenium Medical Technologies – A(H); SkinCeuticals LLC – A(H);
Schedule
Monday, March 4
9:00 AM
Dr. Cox / Introduction
9:05 AM
Dr. Braz / Anatomy for the Injector
9:40 AM
All faculty / Hands-on Stations
Event Details
  • Date
    Monday, March 4
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 144A
  • CME Credits
    3.00
  • Type
    Ticketed
    MOC
    Restricted
Directors/Co-Directors
  • Sue Ellen Cox, MD, FAAD
Speakers
  • Andre Braz, MD
  • Anthony Rossi, MD, FAAD
  • Dee Anna Glaser, MD, FAAD
  • Jeremy Green, MD, FAAD
  • Julie Woodward, MD
  • Kathleen M. Welsh, MD, FAAD
  • Seth L. Matarasso, MD, FAAD
  • Susan H. Weinkle, MD, FAAD
  • Vince Bertucci, MD, FAAD